A detailed history of Intact Investment Management Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Intact Investment Management Inc. holds 10,100 shares of MRNA stock, worth $322,392. This represents 0.02% of its overall portfolio holdings.

Number of Shares
10,100
Holding current value
$322,392
% of portfolio
0.02%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 10, 2025

BUY
$36.85 - $63.93 $372,185 - $645,693
10,100 New
10,100 $419,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $12.5B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Intact Investment Management Inc. Portfolio

Follow Intact Investment Management Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Intact Investment Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Intact Investment Management Inc. with notifications on news.